In English | En español
Questions About Cancer? 1-800-4-CANCER

Coordinating Center for Clinical Trials

Page Options

  • Print This Page
  • Email This Document

Pediatric Leukemia and Lymphoma Steering Committee

The Pediatric Leukemia and Lymphoma Steering Committee (PLLSC) was established in 2011. PLLSC members include representatives from the Children's Oncology Group, pediatric and medical oncologists and other specialists, translational scientists, biostatisticians, patient advocates, and NCI staff.

Mission Statement

The PLLSC follows a data-driven, transparent process to identify and promote the best science in clinical research for pediatric and adolescent patients with leukemia, lymphoma, and other hematologic malignancies by evaluating and prioritizing phase II and phase III clinical trial concepts.

Roster of Pediatric Leukemia and Lymphoma Steering Committee (PLLSC) members
Robert Arceci, M.D., Ph.D. - Chair; William L. Carroll, M.D. - Vice Chair

Clinical Trial Planning Meetings (CTPM)

The Goal of CTPMs is to:

  • identify strategic directions for clinical trials in a specific field
    • reach consensus on the most important clinical trials to conduct;
    • identify portfolio gaps and emerging scientific opportunities;
    • identify innovative trial design opportunities;
  • facilitate innovation and collaboration among the broad oncology community active in the specific cancer under study

List of Clinical Trial Planning Meetings (CTPM) Executive Summaries and Publications

Protocols

To search all active clinical trials, go to: http://www.cancer.gov/clinicaltrials/search

CCCT Contact: Wolf Lindwasser, Ph.D.